Mar 2014 $20 M No. 5 $10 to $50 million 20
Sequent Medical, Inc.: Raise no. 5, Mar 2014 × Investors in this round 20 investors had bought by the notice of Nov 14, 2014: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kevin J. Cousins · Executive Officer Robert F. Rosenbluth · Executive Officer, Director Thomas C. Wilder, III · Executive Officer, Director Brian J. Cox · Director Donald B. Milder · Director James J. Bochnowski · Director Jonathan B. Root · Director Kirk G Nielsen · Director Nimesh F. Shah · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kevin J. Cousins, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 14, 2014. Read the notice at the SEC .
equity SEC Mar 2012 $26 M No. 4 $10 to $50 million 24
Sequent Medical, Inc.: Raise no. 4, Mar 2012 × Investors in this round 24 investors had bought by the notice of Mar 19, 2012: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $26 M of $26 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert F. Rosenbluth · Executive Officer, Director Thomas C. Wilder, III · Executive Officer, Director Brian J. Cox · Director Donald B. Milder · Director Jonathan B. Root · Director Kirk G Nielsen · Director Nimesh F. Shah · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas C. Wilder, III, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 19, 2012. Read the notice at the SEC .
equity SEC May 2010 $16 M No. 3 $10 to $50 million 10
Sequent Medical, Inc.: Raise no. 3, May 2010 × Investors in this round 10 investors had bought by the notice of May 12, 2010: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $16 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert F. Rosenbluth · Executive Officer, Director Thomas C. Wilder · Executive Officer, Director Brian J. Cox · Director Donald B. Milder · Director Jonathan B. Root · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas C. Wilder, III, Chief Executive Officer. Source: SEC Form D, newest notice filed May 12, 2010. Read the notice at the SEC .
equity SEC Mar 2010 $1 M No. 2 Under $2 million 3
Sequent Medical, Inc.: Raise no. 2, Mar 2010 × Investors in this round 3 investors had bought by the notice of Mar 18, 2010: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert F. Rosenbluth · Executive Officer, Director Thomas C Wilder · Executive Officer, Director Brian J. Cox · Director Donald B. Milder · Director Jonathan B. Root · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas C. Wilder, III, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 18, 2010. Read the notice at the SEC .
debt, options SEC May 2009 $3 M No. 1 $2 to $10 million 14
Sequent Medical, Inc.: Raise no. 1, May 2009 × Investors in this round 14 investors had bought by the notice of May 12, 2009: 11 accredited, 3 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in De People named in the notice Robert F. Rosenbluth · Executive Officer, Director Brian J. Cox · Director Donald B. Milder · Director Jonathan Root · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brian J. Cox, Secretary. Source: SEC Form D, newest notice filed May 12, 2009. Read the notice at the SEC .
equity SEC